| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |